Skip to main content
Download PDF

Risk factors associated with malaria infection along China–Myanmar border: a case–control study

Malaria Journal volume 21, Article number: 288 (2022) Cite this article

Abstract

Background

The World Health Organization (WHO) has certificated China malaria free, but imported malaria is a continuous challenge in preventing reintroduction of malaria in the border area of China. Understanding risk factors of malaria along China–Myanmar border is benefit for preventing reintroduction of malaria in China and achieving the WHO’s malaria elimination goal in the Greater Mekong Subregion (GMS).

Methods

This is a case–control study with one malaria case matched to two controls, in which cases were microscopy-confirmed malaria patients and controls were feverish people with microscopy-excluded malaria. A matched logistic regression analysis (LRA) was used to identify risk factors associated with malaria infection.

Results

From May 2016 through October 2017, the study recruited 223 malaria cases (152 in China and 71 in Myanmar) and 446 controls (304 in China and 142 in Myanmar). All the 152 cases recruited in China were imported malaria. Independent factors associated with malaria infection were overnight out of home in one month prior to attendance of health facilities (adjusted odd ratio [AOR] 13.37, 95% confidence interval [CI]: 6.32–28.28, P < 0.0001), staying overnight in rural lowland and foothill (AOR 2.73, 95% CI: 1.45–5.14, P = 0.0019), staying overnight at altitude < 500 m (AOR 5.66, 95% CI: 3.01–10.71, P < 0.0001) and streamlets ≤ 100 m (AOR9.98, 95% CI: 4.96–20.09, P < 0.0001) in the border areas of Myanmar; and people lacking of knowledge of malaria transmission (AOR 2.17, 95% CI: 1.42–3.32, P = 0.0004).

Conclusions

Malaria transmission is highly focalized in lowland and foothill in the border areas of Myanmar. The risk factors associated with malaria infection are overnight staying out of home, at low altitude areas, proximity to streamlets and lack of knowledge of malaria transmission. To prevent reintroduction of malaria transmission in China and achieve the WHO goal of malaria elimination in the GMS, cross-border collaboration is continuously necessary, and health education is sorely needed for people in China to maintain their malaria knowledge and vigilance, and in Myanmar to improve their ability of personal protection.

Background

Malaria is an anopheline mosquito-borne parasitic disease [1], and remains one of main global public health threats. Due to health service disruptions during the coronavirus disease 2019 (COVID-19) pandemic, there were an estimated 241 million malaria cases in 2020, increased from 227 million in 2019, and malaria deaths increased by 12% compared with 2019, to an estimated 627 thousand [2]. The goal of the World Health Organization (WHO) is to eliminate malaria in all countries of the Greater Mekong Subregion (GMS) by 2030 [3]. Cross-border malaria transmission keeps a regional impediment towards malaria elimination in the GMS [4]. China (Yunnan) has malaria ecology and vector system similar to those of five other countries in the GMS. The investigation of risk factors of border malaria can provide scientific evidences in planning malaria elimination in the GMS. After the national malaria programme and its partners dedicated efforts for seven decades, the WHO certified China malaria-free status on June 30, 2021 [5]. However, Yunnan Province shares 4060 km of border with Myanmar (1997 km), Laos (710 km) and Vietnam (1353 km). The interruption of malaria transmission in northern Vietnam has been reported [6, 7]. Malaria towards the subnational elimination goal has also reported in northern Laos [8]. Threat of imported malaria is therefore slight from Vietnam and Lao PDR to China [9]. Malaria was also effectively controlled in most parts of the China–Myanmar border [10]. However, Yunnan borders Myanmar’s five local ethnic special regions that are partly out of the central government management of Myanmar Union. Some parts of the special regions, such as Kachin Special Region II (KR2) and Kongkang Autonomous Regions, are currently in military conflicts. Health services of the Ethnic Health Organizations are too weak to control malaria effectively. Malaria is highly endemic in some of the Myanmar border area [11]. Knowing risk factors of malaria infection well would be helpful in preventing reintroduction of malaria transmission in Yunnan and elimination in Myanmar.

In high endemic situation, risk factors can be investigated through representative cross sectional surveys. In malaria elimination setting, malaria is increasingly imported, caused by Plasmodium vivax, and clustered demographically in adult men with shared epidemiological risk factors [12]. In the situation of low incidence and elimination, the sectional survey is unlikely to adequately identify malaria cases and associated risk factors because the sectional surveys are unlikely to adequately detect malaria [13]. Case–control study is a well-established tool to investigate rare diseases and identify associated demographic, behavioural, and clinical risk factors, being particularly appropriate for rare diseases. As yet, this method has not been extensively used to the epidemiological study of malaria, which has mostly been investigated in high-endemic settings [14]. To further understand risk factors of malaria infection along the China–Myanmar border, a case–control study was conducted to investigate factors associated malaria infection in five prefectures of China (Yunnan) and a hospital in the KR2 of Myanmar.

Methods

Study design and sample size

The study was a case–control design with one malaria case matched to two controls. The malaria cases were diagnosed by microscopy and the controls were excluded malaria by microscopy too. They were febrile patients who attended the same health facility within a week. To mitigate the potential confounding of age, sex and health status, the controls were also matched on the basis of age (± 5 years), gender and health status without complicated diseases. The intended sample size was calculated by using a 95% two-sided confidence level, 80% power, 20% of cases with exposure and 10% of controls with exposure in Epi Info 7.0 (Centers for Disease Control and Prevention, USA). The sample size calculated was at least a total of 158 cases and 316 controls.

Study sites

More than 95% of the study area is mountainous. The altitudes are from 76.4 m to 6740 m in Yunnan, China and from 120 to 5887 m in Kachin State, Myanmar. In order to recruit enough number of malaria cases for this study, the study covered border areas of five prefectures, namely, Dehong, Baoshan, Lincang, Pu'er and Xishuangbanna in China and the KR2 based on the epidemiology of malaria [10, 11, 14,15,16,17,18,19,20,21,22,23,24,25,26] (Fig. 1). The Laiza City and nearby areas in the KR2 of Myanmar is the hottest spot of malaria along the China–Myanmar border [11]. More than 80% of malaria cases in Yunnan in recent five years were imported from the Laiza City and nearby areas. In recent five years, Yingjiang County of Dehong Prefecture neighbouring the Laiza City and nearby areas reported more than one third of imported malaria cases in Yunnan [25, 26]. The subjects of this study were enrolled from 37 health facilities in five border prefectures of China and the Laiza City Hospital in Myanmar (Fig. 1).

Fig. 1
figure 1

Study site locations, altitudes and number of subjects enrolled at each site

Full size image

Microscopy for malaria parasites is well performed in all of the 38 health facilities involved. Study sites selected in China were former hyperendemic areas where are at a high risk of reestablishing malaria transmission due to existing vectors. The study area with hot climate and adequate precipitation is suitable for the growth and reproduction of mosquitoes and the transmission of malaria. With a complex vector community, Anopheles dirus and Anopheles minimus have been identified as two primary vectors [18, 20]. An. dirus is a well-known exophagic vector, and An. minimus is mainly endophagic with increasing exophagic due to frequent use of insecticides. Perennial malaria transmission can occur in the study area. The peak season of malaria transmission is from June through August each year [18, 20].

Laboratory diagnosis and structure interview

Microscopy for malaria parasites is one of normal test items in the enrolled health facilities. Laboratory technicians were responsible for recruiting the cases and controls. A finger or earlobe prick in febrile patients was performed to generate blood smears. The febrile patients were ones with axillary temperatures of not lower than 37.3 °C within 48 h. The blood slides were stained with Giemsa for microscopy. The malaria cases were recruited from microscopy-confirmed malaria patients between May 2016 and October 2017. Meanwhile, the feverish people with microscopy-excluded malaria were enrolled as controls following informed consent obtained. When laboratory technicians were not excellent, they could not detect malaria from blood slides with low parasite densities, the malaria patients with low parasite densities might be excluded from the malaria case group, and then into the control group. When the laboratory technicians read a negative slide as positive one, the febrile patient might into the case group instead of into the control group. As the quality control, all blood slides were re-read by an expert microscopist with the WHO malaria microscopy level one certificate for the secondary confirmation, namely, to exclude subjects with false positivity and false negativity. A paper-based questionnaire was administered to the subjects in Mandarin in China’s health facilities and in Kachin ethnical language in the Laiza City Hospital of Myanmar. The questionnaire has 36 questions, covering demographics, occupation, activities, travel history, housing condition, local ecology, socio-economic status, behaviour, malaria awareness and knowledge, and preventive measures. In the questionnaire, details of principal household components were recorded to construct a family wealth index (FWI) (Table 1) [27,28,29,30].

Table 1 Principal components for construction of the family wealth index (FWI)
Full size table

Statistical analysis

Data were entered and cleaned in Excel 2007, and then were analyzed in Epi Info 7.2. The statistical associations were based on matched analyses. For the case and the control group, the frequency and its 95% confidence interval (CI) of each predictor variable were calculated, and then compared using a Fisher exact chi-square test. A multivariate logistic regression analysis (LRA) was used to identify risk factors associated with malaria infection. In modeling strategy, the independent variables of univariate LRA were items with values of P < 0.10 in the chi-square test between the cases and the controls. The independent variables were included in the multivariate LRA model if they had a value of p < 0.25 in the univariate LRA. Non-response answers were treated as missing value and therefore excluded from the analyses [14, 31]. The data of subjects recruited in China and Myanmar were analysed, respectively. And then the same methodology was used to analyse the data of overall subjects. The risk factors of malaria infection were finally determined by comparing across the results from the three analyses (for subjects enrolled in China and Myanmar, and the combined).

Results

Subjects’ characteristics

A total of 223 malaria cases and 446 matched controls were recruited to participate in the study. Based on the China Information System for Disease Control and Prevention (CISDCP), all 152 malaria cases enrolled in China satisfied with the CISDCP criteria and were categorized into imported malaria from Myanmar. The CISDCP criteria for an imported malaria case is the malaria patient 1) with overnight stay history in endemic areas of other countries within one month prior to malaria that is diagnosed by laboratory test and 2) with robust evidences of malaria free in the malaria patient’s community in China. A total of 304 matched controls were recruited in the same health facilities. Of the 152 cases, 141 (92.7%) were Plasmodium vivax malaria and 10 (6.6%) Plasmodium falciparum and 1 (0.7%) mixed infection of P. vivax and P. falciparum; the numbers of male, aged < 16, 16–59 and > 60 years old were 120 (79.0%), 10 (6.6%), 138 (90.8%) and 4 (2.6%), respectively (Additional file 1: Table S1). A total of 71 cases and 142 matched controls were enrolled from the Laiza City Hospital in the KR2 of Myanmar. Of the 71 cases, 69 (97.2%) were P. vivax malaria, 1 (1.4%) P. falciparum and 1 (1.4%) mixed infection of P. vivax and P. falciparum; the numbers of male, aged < 16, 16–59 and > 60 years old were 43 (60.6%), 17 (24.0%), 53 (74.6%) and 1 (1.4%), respectively (Additional file 1: Table S2). Among overall 669 research subjects, 489 (73.1%) were male and 180 (26.9%) female; and mean age was 30.6 years old (median: 29.0, range: 1–76). Most of the 223 cases were young male adults, and the 446 controls were matched by age and gender. Of the 223 confirmed malaria case patients, 210 (94.2%) cases were P. vivax malaria, 11 (4.9%) P. falciparum, 2 (0.9%) mixed infection of P. vivax and P. falciparum (Additional file 1: Table S3). The geometric mean parasite density of the malaria patient cases was 3347.5 (rang 174–65 418) parasites per ul. Of the malaria cases, the numbers of male, aged < 16, 16–59 and > 60 years old were 163 (73.1%), 27 (12.1%), 191 (85.7%) and 5 (2.2%), respectively (Additional file 1: Table S3).

Risk factors of malaria cases enrolled in China

The malaria case group and the control group were similar in terms of demographics, proportions living in towns, residence proximity to forest, vector control measures, knowledge of malaria prevention, and engagement in trading, road- building and mining, sight-seeing and lumbering activities in one month prior to enrolling into the study (P > 0.10) (Additional file 1: Table S1). The matched univariate and multivariate LRA identified five independent risk factors associated with malaria infection from subjects recruited in China. Two of the risk factors were overnight in Myanmar (adjusted odd ratio [AOR] 30.31, 95% confidence interval [CI]: 15.42–59.58, P < 0.0001) and overnight out of home (AOR 69.71, 95%CI: 8.59–261.47, P < 0.0001) within one month prior to enrolling into the study. Three of the risk factors were staying overnight in rural lowland and foothill (AOR 3.05, 95%CI: 1.59–5.84, P = 0.0008), staying overnight at altitude < 500 m (AOR 4.59, 95%CI: 2.35–8.97, P < 0.0001) and staying overnight nearby streamlets (≤ 100 m) (AOR 8.08, 95%CI: 2.23–29.25, P = 0.0015) for malaria cases in Myanmar within one month prior to attendance of health facilities (Table 2).

Table 2 Risk factors associated malaria infection in the Yunnan border area, China
Full size table

Risk factors of malaria cases enrolled in Myanmar

The malaria case group and control group were similar in terms of demographics, FWI, nationality, country overnight in one month prior to enrolling into the study, proximity of vegetation, screens of windows and doors, types of bed nets used, knowledge of malaria prevention (P > 0.10) (Additional file 1: Table S2). The matched univariate and multivariate LRA identified four independent risk factors associated with malaria infection from subjects enrolled in Myanmar, namely, staying overnight out of home within one month prior to attendance of health facilities (AOR 2.72, 95%CI: 1.40–5.29, P = 0.0033), staying overnight in Laiza city (AOR 3.44, 95%CI: 1.55–7.64, P = 0.0023), staying overnight at altitude < 500 m (AOR 2.81, 95%CI: 1.21–6.51, P = 0.0161) and streamlets ≤ 100 m (AOR4.63, 95%CI: 1.04–20.57, P = 0.0441) (Table 3).The Laiza city is located in a mountain valley with an altitude from 230 to 260 m and nearby a river and a few of streamlets. Staying in the Laiza city and nearby areas is at a high risk of malaria infection.

Table 3 Risk factors associated malaria infection in Kachin Special region II, Myanmar
Full size table

Risk factors of overall malaria cases

Among overall subjects enrolled in China and Myanmar, the malaria case group and the control group were similar in terms of demographics, education, knowledge and awareness in malaria prevention (P > 0.10) (Additional file 1: Table S3). The matched univariate and multivariate LRA identified six independent risk factors associated with malaria infection. Five of the risk factors were as same as identified from the subsample recruited in China, namely, staying overnight in Myanmar within one month prior to attendance of health facilities, staying overnight out of home, especially staying in rural lowland and foothill, staying overnight at low altitude and proximity (≤ 100 m) of streamlets (Table 4). Due to increased sample size, the variable of no knowledge of malaria transmission, namely, the malaria cases lacking knowledge of malaria transmission by mosquitoes compared to the controls, was identified as one of risk factors associated with malaria infection (AOR2.17, 95%CI: 1.42–3.32, P = 0.0004) (Table 4).

Table 4 Risk factors associated malaria infection along China-Myanmar border
Full size table

Discussion

Risk factors of malaria infection

The low altitude leads to hot temperature and adequate precipitation and then abundant breeding sites of anopheline mosquitoes in the China–Myanmar border area. All results of former investigations documented that people in low altitude areas were at a high risk of malaria infection. A retrospective case–control study suggested that independent risk factors associated with malaria infection were overnight in the lowland, foothill and half-hill areas, and near anopheline mosquito breeding sites in the China–Myanmar border area [14]. A cross-sectional study reported that independent risk factors for slide positivity were age, lower altitude, lack of knowledge about malaria transmission and symptoms, inaction against mosquito bites and delayed treatment-seeking in the Salween river valley of Shan Special Region II (SR2), northern Myanmar [16]. In this study, the comparison of multivariate LRA results between the subjects recruited in China and Myanmar indicated that the risk factors associated with malaria infection were mainly overnight out of homes within one month prior to illness, staying in rural lowland and foothill, staying at altitude < 500 m and streamlets ≤ 100 m in the border areas of Myanmar. For the subsample enrolled in China, the overnight in Myanmar was a part of overnight out of home. For the subsample enrolled in Myanmar, the Laiza city and nearby areas was altitude < 500 m and streamlets ≤ 100 m, staying in the Laiza city and nearby areas was therefore at a high risk of malaria infection. The LRA result of the overall sample indicated that no knowledge of malaria transmission was a risk factor of malaria infection due to the increased sample size. The proportion of case-patients with knowledge of malaria transmission (67.3%) was significantly lower than that of controls (77.6%) (P = 0.0055). This indicates that health education on malaria should be necessary for people in both China and Myanmar. The public health in China should maintain people’s malaria knowledge and vigilance, and remind people using personal protection against malaria infection when they are in the endemic areas of other countries. Cross-border workers should be educated on preventive measures for malaria through effective behaviour change communication [25].

Malaria along China–Myanmar border and other parts in Southeast Asia

In most areas of the Southeast Asia, the year-round high rainfall and temperatures, and abundant malaria vectors lead to persistent and intense malaria transmission. Most parts of the GMS are low latitude and altitude, and suitable for fertility of malaria vectors and persistent malaria transmission [32]. Forests are traditionally considered as a major determinant of malaria risk in the GMS [33, 34]. In Vietnam a high proportion of malaria cases and deaths were reported in the central mountainous and forested areas [35]. In Myanmar, most of malaria cases were reported to occur in forest or forest fringe areas, and loggers and gem miners were at high risk of malaria [36, 37]. However, the China–Myanmar border areas with altitude from 200 m through 5887 m are mostly mountainous. The low altitude areas have high temperatures, adequate mosquito breeding sites and malaria vectors [14]. After malaria was effectively controlled along the China–Myanmar border [10], the major malaria hot spots are the Laiza and its nearby areas of the KR2 [18, 19], the Salween river valley of the SR2 [15, 16] and the small golden triangle at China–Myanmar–Laos border in the Mekong River Valley [4, 11] in the northern Myanmar. All the three malaria hot spots are low altitude. The two former investigations [14, 16] and this study did not identify malaria in association with forest in the northern Myanmar. This documents that the heterogeneity and complexity of malaria should be considered in planning control and elimination programmes in the GMS [38].

Malaria epidemiological characteristics along China–Myanmar border

In eliminating settings, malaria cases are increasingly male, adult, clustered geographically, imported among migrant and other hard-to reach groups, and caused by P. vivax [12, 14]. All of 152 malaria cases recruited in China were imported among migrants, and most of them were male, adult and P. vivax malaria. In the chi-square test, the proportions of male and aged ≥ 16 year old malaria cases recruited in China were significantly higher than the proportions of malaria cases recruited in Myanmar (male, x2 = 7.4081, P = 0.0065; age, x2 = 12.1295, P = 0.0060). The proportions of P. vivax between two subsamples were not significant (x2 = 1.0111, P = 0.3146), which is one of evidences of the same infection locations. When the high percentage of P. vivax malaria indicates the success in control of P. falciparum malaria [10], it also documents the difficulty in control and elimination of P. vivax [18].

Implications

The WHO certification of malaria elimination requires applicant countries to provide evidence that 1) local malaria transmission has been fully interrupted, resulting in zero indigenous human malaria cases for at least the past three consecutive years (36 months), and 2) an adequate program for preventing reintroduction of malaria transmission is fully functional throughout the country [39, 40]. The last indigenous malaria case in China was reported from Yingjiang County in the Yunnan border area in April 2016 [41]. Malaria elimination in the Yunnan border area has strongly contributed to the remarkable achievement that the WHO certified China malaria-free status on June 30, 2021 [5, 11]. The results of this study helped public health decision-makers planning cost-effective strategies of malaria elimination gearing to the high-risk locations and populations [11]. However, the Yunnan border area is still challenged by reintroduction of malaria transmission. The threat of imported malaria from the border areas of Myanmar will continuously exist for a long time. With understanding the local risk factors of malaria infection, the ‘‘3 + 1’’ strategy for intensive surveillance, rapid response and border collaboration for malaria elimination was developed to reduce the threat of imported malaria for malaria elimination and preventing reintroduction of malaria transmission in the Yunnan border area [11].

Reduced border collaboration of malaria had ever led to slightly resurgent malaria in some border areas of Myanmar since 2014 [11, 15, 18]. The Laiza and nearby areas of the KR2 with a population of approximately 30 thousand persons is one of the malaria hotspot areas along China–Myanmar border due to the risk factors presented in this paper and the weak health services [11]. The number of malaria cases increased from 518 in 2013 to 2,367 in 2016 in the Laiza and nearby areas. The strengthened collaborative interventions between China and Myanmar during 2017–2019 reduced the number of malaria cases to 274 in 2019 [11]. However, reduced collaborative interventions due to the COVID-19 pandemic led to malaria resurgence again. In 2021, a total of 1,532 cases were reported in the Laiza and nearby areas of KR2. This led to importation of most of malaria cases in Yunnan from the Laiza and nearby areas in 2021. Yunnan province mainly borders Myanmar’s five special regions that are out of the central government management of Myanmar Union. The military conflicts and the weak health services cannot effectively control malaria in the five special regions. The risk factors presented in this paper can be referred in planning cross-border collaboration of malaria control.

Limitations

This study has certain weaknesses, which might be the limitations of the case–control study itself too. 1) To mitigate the confounding effect, controls were matched with age, sex, healthy status, health facilities and treatment-seeking dates. The matching criteria make the study lose the chance to identify whether they are an independent risk or confounding factors of malaria infection. 2) Because the Laiza and nearby areas are the main malaria hot spot that exported most of malaria cases (> 80%) detected in Yunnan, this study only recruited the subjects from the Laiza city hospital in Myanmar. Due to malaria scarceness, the subjects were enrolled from 37 health facilities in China. The large difference in the number of health facilities involved in this study between China and Myanmar may be one of weakness. However, malaria cases that were recruited in China were imported from most parts of the border areas of Myanmar. This would not lead to selection bias. 3) Among the 304 controls recruited in China, 259 (85.2%) had no overnight history in Myanmar in one month prior to attendance of health facilities. The high proportion of non-malaria febrile patients without overnight history in Myanmar might influence assessment of other potential risk factors. However, this can document that overnight in Myanmar is an obvious risk factor for Chinese people. 4) The subjects were only recruited in the health facilities. If some patients just bought anti-malarial drugs from the drug stores for malaria treatment and the self-medication worked, they might not seek diagnosis and treatment in the health facilities. This occasion might lead to exclusion of them from the study. However, with reduction of malaria burden, anti-malarial drugs are disappearing from drug stores because of losing chance of making money from anti-malarial drugs. This leads to anti-malarial drugs mainly available in the public health facilities in China. The chance of the selection bias should be small. 5) Some participants declined to answer certain questions that they thought of as sensitive, this might cause responding bias. 6) To avoid recall bias, most of variables were defined to collect information in one month prior to attendance of health facilities. This may miss to collect enough valuable information. 7) Primaquine is administered over a 14-day period in Myanmar [18] and for double eight days in China [42] to kill liver-stage parasites. With primaquine administration for radical cure treatment, the proportion of P. vivax malaria relapse was considered low, so that the previous malaria history was not included in the questionnaires in the study design. The previous malaria history did not thereby included in the LRA model. Any further study should consider the issue of the relapse of P. vivax malaria in the study area.

Conclusion

All malaria cases were infected in Myanmar. The Laiza and nearby areas are the dominant reservoirs of malaria parasites along China–Myanmar border. Plasmodium vivax is the dominant malaria parasites, and most malaria patients are male and adult. The independent risk factors of malaria infection are overnight out of home, staying in rural lowland and foothill, low altitude areas and nearby local vector breeding sites in the border areas of Myanmar; and subjects lacking knowledge of malaria transmission. To prevent reintroduction of malaria transmission in China and achieve the WHO malaria elimination goal in the GMS, cross-border collaboration is continuously necessary. Health education is sorely needed for people in China to maintain their malaria knowledge and vigilance, and in Myanmar to promote their ability to apply personal protection.

Availability of data and materials

Not applicable.

Abbreviations

AOR:

Adjusted odds ratio

CI:

Confidence interval

COVID-19:

Coronavirus disease 2019

WHO:

World Health Organization

GMS:

Greater Mekong Subregion

KR2:

Kachin Special Region II

FWI:

Family wealth index

LRA:

Logistic regression analysis

SR2:

Shan Special Region II

References

  1. Alonso PL, Tanner M. Public health challenges and prospects for malaria control and elimination. Nat Med. 2013;19:150–5.

    Article  CAS  PubMed  Google Scholar 

  2. WHO. World Malaria Report 2020. Geneva: World Health Organization; 2021.

    Google Scholar 

  3. WHO. Strategy for malaria elimination in the Greater Mekong Subregion: 2015–2030. Geneva: World Health Organization; 2015.

    Google Scholar 

  4. Geng T, Malla P, Zhang Q, Xu S, Li C, Zhao Y, et al. Increasing trends of malaria in a border area of the Greater Mekong Subregion. Malar J. 2019;18:309.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Cao J, Newby G, Cotter C, Hsiang M, Larson E, Tatarsky A, et al. Achieving malaria elimination in China 2021. Lancet Public Health. 2021;6:e871-872.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Morillon M, Baudon D, Dai B. [Malaria in Vietnam in 1996: brief synthesis of epidemiological data] (in French). Med Trop (Mars). 1996;56:197–200.

    CAS  Google Scholar 

  7. Thanh PV, Hong NV, Van NV, Malderen CV, Obsomer V, Urgell AR, et al. Epidemiology of forest malaria in Central Vietnam: the hidden parasite reservoir. Malar J. 2015;14:86.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Kounnavong S, Gopinath D, Hongvanthong B, Khamkong C, Sichanthongthip O. Malaria elimination in Lao PDR: the challenges associated with population mobility. Infec Dis Poverty. 2017;6:81.

    Article  Google Scholar 

  9. Xu JW, Li JJ, Guo HP, Pu SW, Li SM, Wang RH, et al. Malaria from hyperendemicity to elimination in Hekou County on China-Vietnam border: an ecological study. Malar J. 2017;16:66.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Xu JW, Li Y, Yang HL, Zhang J, Zhang ZX, Yang YM, et al. Malaria control along China–Myanmar border during 2007–2013: an integrated impact evaluation. Inf Dis Poverty. 2016;5:75.

    Article  Google Scholar 

  11. Xu JW, Lee R, Lin ZR, Zhou YW, Shen HM, Zhou HN, et al. Intensive surveillance, rapid response and border collaboration for malaria elimination: China Yunnan’s ‘“3+1”’ strategy. Malar J. 2021;20:396.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Cotter C, Sturrock HJ, Hsiang MS, Liu J, Phillips AA, Hwang J, et al. The changing epidemiology of malaria elimination: new strategies for new challenges. Lancet. 2013;382:900–16.

    Article  PubMed  Google Scholar 

  13. Hsiang MS, Hwang J, Kunene S. Surveillance for malaria elimination in Swaziland: a national cross-sectional study using pooled PCR and serology. PLoS ONE. 2012;7: e29550.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Xu JW, Liu H, Zhang Y, Guo XR, Wang JZ. Risk factors for border malaria in a malaria elimination setting: a retrospective case-control study in Yunnan. China Am J Trop Med Hyg. 2015;92:546–515.

    Article  PubMed  Google Scholar 

  15. Liu H, Xu JW, Yang HL, Li Mei, Sun CD, Yin YJ, et al. Investigation and control of a Plasmodium falciparum malaria outbreak in Shan Special Region II of Myanmar along the China-Myanmar Border from June to December 2014. Inf Dis Poverty. 2016;5:32.

  16. Liu H, Xu JW, Xu QZ, Zeng YR. Retrospective analysis of risk factors of slide positivity among febrile patients in the Salween river valley of Shan Special Region II, northern Myanmar. BMC Public Health. 2018;18:560.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Xu JW, Liu H. The challenges of malaria elimination in Yunnan Province, People’s Republic of China. Southeast Asian J Trop Med Public Health. 2012;43:819–24.

    PubMed  Google Scholar 

  18. Liu H, Xu JW, Bi Y. Malaria burden and treatment targets in Kachin Special Region II, Myanmar from 2008 to 2016: a retrospective analysis. PLoS ONE. 2018;13: e0195032.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Xu JW, Liu H. The relationship of malaria between Chinese side and Myanmar’s five special regions along China-Myanmar border: a linear regression analysis. Malar J. 2016;15:368.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Liu H, Xu JW, Guo XR, Havumaki J, Lin YX, Yu GC, et al. Coverage, use and maintenance of bed nets and related influence factors in Kachin Special Region II, northeastern Myanmar. Malar J. 2015;14:212.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Liu H, Yang H, Xu JW, Wang JZ, Nie RH, Li CF, et al. Artemisinin–naphthoquine combination versus chloroquine–primaquine to treat vivax malaria: an open-label randomized and non-inferiority trial in Yunnan Province China. Malar J. 2013;12:409.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Xu JW, Xu QZ, Liu H, Zeng YR. Malaria treatment-seeking behaviour and related factors of Wa ethnic minority in Myanmar: a cross-sectional study. Malar J. 2012;11:417.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Liu H, Yang HL, Tang LH, Li XL, Huang F, Wang JZ, et al. Monitoring Plasmodium vivax chloroquine sensitivity along China-Myanmar border of Yunnan Province, China during 2008–2013. Malar J. 2014;13:364.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Liu H, Yang HL, Tang LH, Li YL, Huang F, Wang JZ, et al. In vivo monitoring of dihydroartemisinin- piperaquine sensitivity in Plasmodium falciparum along the China-Myanmar border of Yunnan Province, China from 2007 to 2013. Malar J. 2015;14:47.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Zhao X, Thanapongtharm W, Lawawirojwong S, Wei C, Tang Y, Zhou Y, Sun X, et al. Spatiotemporal trends of malaria in relation to economic development and cross-border movement along the China-Myanmar border in Yunnan Province. Korean J Parasitol. 2020;58:267–78.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Zhao X, Lawawirojwong S, Thanapongtharm W, Wei C, Tang Y, Zhou Y, Sun X, et al. Malaria risk map using spatial multi-criteria decision analysis along Yunnan Border during the pre-elimination period. Am J Trop Med Hyg. 2020;103:793–809.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Vyas S, Kumaranayake L. Constructing socio-economic status indices: how to use principal components analysis. Health Policy Plan. 2006;21:459–68.

    Article  PubMed  Google Scholar 

  28. Xu J-W, Liu H, Yaw B, Nbwi HS. The health beliefs, dengue knowledge and control behaviors among internally displaced persons versus local residents in Kachin Special Region II, Myanmar. PLoS Negl Trop Dis. 2020;14: e0008321.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Xu JW, Liu H, Ai D, Yu Y, Yu B. The Shan people’s health beliefs, knowledge and perceptions of dengue in Eastern Shan Special Region IV Myanmar. PLoS Negl Trop Dis. 2019;13: e0007498.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Liu H, Xu JW, Ai Z, et al. Treatment seeking behavior and associated factors of suspected dengue fever among Shan people in eastern Shan special region IV, Myanmar: a cross-sectional study. BMC Health Serv Res. 2020;20:318.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Ward KA, Spokes PJ, McAnulty JM. Case–control study of risk factors hospitalization caused by pandemic (H1N1) 2009. Emerg Infect Dis. 2011;17:1409–16.

    PubMed  PubMed Central  Google Scholar 

  32. Prothero RM. Malaria, forests and people in Southeast Asia. Singap J Trop Geogr. 1999;20:76–85.

    Article  Google Scholar 

  33. Mekong RBM. Mekong Malaria II: update of malaria, multi-resistance and economic development in the Mekong Region of Southeast Asia. Southeast Asian J Trop Med Public Health. 2003;34(Suppl):68–70.

    Google Scholar 

  34. Guerra CA, Snow RW, Hay SR. A global assessment of closed forests, deforestation and malaria risk. Ann Trop Med Parasitol. 2006;100:189–204.

    Article  CAS  PubMed  Google Scholar 

  35. Erhart A, Thang ND, Ky PV, Tinh TT, Overmeir CV, Speybroeck N, et al. Epidemiology of forest malaria in central Vietnam: a large scale cross-sectional survey. Malar J. 2005;4:58.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Delacollette C, Souza C, Christophe E, Thimasarn K, Abdur R, Bell D, et al. Malaria trends and challenges in the greater Mekong Subregion. Southeast Asian J Trop Med Public Health. 2009;40:674–91.

    PubMed  Google Scholar 

  37. Dunning J, Aung NKZ, Ward A, Aye MM, Lourenço C, Gallalee S, et al. Key factors associated with malaria infection among patients seeking care through the public sector in endemic townships of Ayeyarwady Region Myanmar. Malar J. 2022;21:86.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Cui L, Yan G, Sattabongkot J, Cao Y, Chen B, Chen X, et al. Malaria in the Greater Mekong Subregion: heterogeneity and complexity. Acta Trop. 2012;121:227–39.

    Article  PubMed  Google Scholar 

  39. WHO. Malaria elimination: a field manual for low and moderate endemic countries. Geneva: World Health Organization; 2014.

    Google Scholar 

  40. WHO. A framework for malaria elimination. Geneva: World Health Organization; 2017.

    Google Scholar 

  41. Zhao X, Sun X, Yang H, Zhou D, Yang J, Guo T, et al. A report of the last indigenous malaria case in Yunnan (in Chinese). China Trop Med. 2020;20:325–8.

    Google Scholar 

  42. Xu JW, Lee R, Li X, Liu H. Transition of radical, preventive and presumptive treatment regimens for malaria in China: a systematic review. Malar J. 2021;20:10.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank all participants for their contribution of time and patience in the study. We would like to thank Dr Liu Hui from Yunnan Institute of Parasitic Diseases for her coordination of the investigation and Ms Li Huiqiong from Yunnan Simao Sanmu Group for the entry of the data. The opinions expressed are those of the authors and do not necessarily reflect those of the above-mentioned organizations and people.

Funding

This work was supported by the National Natural Science Foundation of China (Nos. 81560543 and 81673113).

Author information

Authors and Affiliations

  1. Yunnan Institute of Parasitic Diseases, Yunnan Provincial Centre of Malaria Research; Yunnan Provincial Key Laboratory of Vector-borne Disease Control and Research; Yunnan Institute of Parasitic Diseases Innovative Team of Key Techniques for Vector Borne Disease Control and Prevention; Training Base of International Scientific Exchange and Education in Tropical Diseases for South and Southeast Asia, Puer, 665000, China

    Jian-Wei Xu, Dao-Wei Deng, Chun Wei, Xing-Wu Zhou & Jian-Xiong Li

Authors
  1. Jian-Wei Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dao-Wei Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chun Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xing-Wu Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jian-Xiong Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

JWX conceived the study idea, analyzed the data and wrote the manuscript. JWX, DWD, CW, XWZ and JXL contributed towards the study design, data interpretation and rigorous manuscript review. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Jian-Wei Xu.

Ethics declarations

Ethics approval and consent to participate

The ethical approval of study (YIPDEA 201502) was granted by the Ethics Committee of the Yunnan Institute of Parasitic Diseases in China. The study was also approved by the Department of Health of the Kachin Independence Organization, Myanmar. The ethical approval documented a verbal consent procedure as sufficient because microscopy for malaria parasites is the golden standard for malaria diagnosis and one of normal test items in these health facilities, and the study was interviewed-based. According to the World Medical Association Declaration of Helsinki, the purpose and procedures of the study were explained and disclosed to the participants before obtaining their verbal informed consent. For the child participants, a statement that verbal informed consent was obtained from their parents or guardians. The questionnaire was administered following a verbal informed consent. Participation was entirely voluntary, and participants could pass on a question, take a break or withdraw their consent from the study without providing any explanation at any time. Their continued consent was assumed if they did not refuse to answer questions.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Additional tables.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Xu, JW., Deng, DW., Wei, C. et al. Risk factors associated with malaria infection along China–Myanmar border: a case–control study. Malar J 21, 288 (2022). https://doi.org/10.1186/s12936-022-04312-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12936-022-04312-5

Keywords

  • Malaria
  • Risk factors
  • Cross-border collaboration
  • China
  • Myanmar
  • Greater Mekong Subregion

Malaria Journal

ISSN: 1475-2875

Contact us